ENTITY
Avid Bioservices

Avid Bioservices (CDMO US)

8
Analysis
Health Care • United States
Avid Bioservices, Inc. operates as a pharmaceutical company. The Company focuses on development and manufacturing of biopharmaceutical products derived from mammalian cell culture, as well as provides clinical and commercial manufacturing services. Avid Bioservices serves customers in the United States.
more
bullish•Avid Bioservices
•07 Dec 2020 10:50

Avid Bioservices: Strong Quarterly Performance Led to 25%+ Re-Rating Last Week. More to Go.

Avid is doing all the right things since it became a pure-play CDMO in CY2017. Over last 3 months, the stock has been up 65%+ led by strong...

Logo
318 Views
Share
bullish•Avid Bioservices
•05 Sep 2020 20:25
Logo
364 Views
Share
bullish•Avid Bioservices
•20 Aug 2020 08:59

US Hidden Gems | Avid Bioservices: Transitioning Avidly to Pure-Play Biologics CDMO

Avid Bioservices Inc (CDMO US) (“Avid”) is a $480mm market-cap US based pure-play biologics CDMO (Contract Development & Manufacturing...

Logo
426 Views
Share
x